TCS, HDFCBANK, SBI Liquid Fund (G)
Syncom Formulations (India) Ltd.
Syncom Formulations
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 30 06 2021 | Quarterly Results & Audited Results |
| 14 08 2021 | Quarterly Results |
| 27 08 2021 | Inter alia, to consider and approve : 1. To consider and approve conversion of warrants into the equity shares of the company to the promoter and promoter group subject to depositing of the balance outstanding amount for conversion of warrants into the equity shares of the company. 2. Approval of the Boards Report, Corporate Governance Report and Notice of the 33rd Annual General Meeting. 3. Approval of the Book closure for the purpose of 33rd Annual General Meeting. 4. Approval of the cut-off date for eligibility to participate in the Remote E-voting and E- voting at 33rd Annual General Meeting. 5. To appoint Scrutinizer for the process of remote E-voting as well as E-voting at AGM. 6. Re-appointment of Shri Kedarmal Shankarlal Bankda (DIN:00023050) as the Executive Chairman/Whole-time Director of the Company. 7. To consider and approve other matter incidental thereto. |
| 13 11 2021 | Quarterly Results |
| 14 02 2022 | Quarterly Results |
| 25 02 2022 | Preferential Issue of shares Inter alia, to consider and approve (a) the conversion of warrants into the equity shares of the Company to the Promoter and Promoter Group subject to the depositing the balance outstanding amount for conversion of warrants into the equity shares of the Company. b) any other matter incidental thereto. |
| 18 05 2022 | Audited Results |
| 28 05 2022 | Preferential Issue of shares Inter alia, to consider and approve the following businesses along with other routine businesses: a) To consider and approve conversion of warrants into the equity shares of the Company to the Promoter and Promoter Group subject to the depositing the balance outsianding amount for conversion of warrants into the equity shares of the company. b) To consider and approve any other matter incidental theret |
| 13 08 2022 | Quarterly Results & Final Dividend Inter alia, to consider:- c) the Boards Report, Corporate Governance Report and Notice of the 34th AGM; d) the Book closure for the purpose of 34th AGM; e) the cut-off date for eligibility to participate in the Remote E-voting and E- voting at 34th AGM; f) To appoint Scrutinizer for the process of remote E-voting as well as E-voting at AGM; g) Re-appointment of Smt. Rinki Ankit Bankda (DIN: 06946754) as the Whole-time Director of the Company; h) To consider and recommend the Final dividend, if any, on equity shares of the Company for the Financial Year ended 31st March, 2022 subject to approval of members at the ensuing AGM; i) To consider the matter related to appointment/re-appointment of Statutory Auditor upon conclusion of the term of 5 years in the ensuing AGM; j) To consider and approve other matter incidental thereto. |
| 14 11 2022 | Quarterly Results |
| 13 02 2023 | Quarterly Results |
| 29 05 2023 | Audited Results |
| 14 08 2023 | Quarterly Results |
| 08 11 2023 | Quarterly Results |
| 14 02 2024 | Quarterly Results |
| 11 11 2024 | Quarterly Results |
News
No News data available
